Why Imricor, Imugene, Newmont, and Pepper Money shares are falling today

These shares are having a tough time on hump day. But why?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a large decline. At the time of writing, the benchmark index is down 0.9% to 8,555.5 points.

Four ASX shares that are falling more than most today are listed below. Here's why they are dropping:

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.

Image source: Getty Images

Imricor Medical Systems Inc (ASX: IMR)

The Imricor Medical Systems share price is down over 2% to $1.17. Investors have been selling this medical technology company's shares this month after it revealed that the US approval process for its 3D MRI mapping system, NorthStar, has been delayed. Morgans remains upbeat, though. It said: "The share price has dropped 20% this morning, which we see as a complete overreaction. Therefore, a great buying opportunity has emerged. There are plenty of catalysts coming over the next few quarters which will drive the share price higher including the expected approval of the NorthStar mapping system. We have made no changes to our forecasts or valuation. We maintain a speculative buy recommendation on IMR."

Imugene Ltd (ASX: IMU)

The Imugene share price is down almost 12% to 37.5 cents. This follows news that the clinical stage immuno-oncology company has received firm commitments from institutional and sophisticated investors for a $22.5 million placement. These funds are being raised through the issue of 68.2 million shares at a 22% discount of 33 cents per new share. The company advised that the proceeds of the capital raising will primarily be used to fund the azer-cel program through to initiating a pivotal clinical trial in 2026. Post completion, Imugene will have a pro-forma cash balance of $64 million. With anticipated R&D rebates and other cost saving initiatives, it expects to have funding into second half of 2026. In addition, the potential exercise of attaching options provides for up to a further $36.6 million of near-term funding.

Newmont Corporation (ASX: NEM)

The Newmont Corporation share price is down 5% to $88.27. Investors have been selling gold miners today after the gold price pulled back overnight. This has seen the S&P/ASX All Ordinaries Gold index weigh heavily on the market today with a 2.5% decline. Despite today's weakness, Newmont Corporation shares are up approximately 46% year to date.

Pepper Money Ltd (ASX: PPM)

The Pepper Money share price is down 3.5% to $1.86. This has been driven by the release of a broker note out of the Macquarie equities desk this morning. According to the note, the broker has downgraded this non-bank lender's shares to a neutral rating with an improved price target of $1.70. While the broker believes that the current environment is favourable for non-bank lenders like Pepper Money, it thinks that this is now firmly priced into its share price.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

Codan share price A dismayed kid dressed as a scientist stands with his back to a rocket crashed into the ground
Share Fallers

Xero shares crash to a 7-year low after a brutal sell-off

The decline has wiped out years of share price gains.

Read more »

Two miners at a mine site on their tablets, with mining machinery behind them.
Share Fallers

Why has the Mineral Resources share price fallen 12% this week?

It’s been another tough week for Mineral Resources shareholders.

Read more »

A man holds his hand to his chin with a furrowed brow, making an expression of puzzlement or confusion.
Share Fallers

Top 3 ASX 200 shares now below their 200-day moving average

Are these businesses still a buy?

Read more »

A young man clasps his hand to his head with a pained expression on his face and a laptop in front of him.
Share Fallers

What are the most shorted ASX shares on the market right now?

Two names, two opposite bear cases.

Read more »

An arrow crashes through the ground as a businessman watches on.
Share Fallers

Warning: Corporate Travel shares have crashed 80%. What on earth just happened?

An 80% crash has left investors asking what went so wrong.

Read more »

Stressed businessman sits in panic amid digital stock market financial background.
Share Fallers

The five worst-performing ASX 200 shares in August unmasked

Investors sent these five ASX shares crashing 17% to 23% in August. But why?

Read more »

Stressed businessman sits in panic amid digital stock market financial background.
Share Fallers

Why Megaport, Lendlease and JB Hi-Fi shares all crashed 14% to 15% this week

ASX investors punished Lendlease, Megaport, and JB Hi-Fi this week. But why?

Read more »

Woman checking out new laptops.
Consumer Staples & Discretionary Shares

Down 14% today: Are JB Hi-Fi shares now a bargain-bin buy?

Could JB's plunge mean a bargain buy?

Read more »